The pandemic catalyzed a fundamental shift where individuals became more proactive and self-directed in managing their health, moving beyond traditional medicine. This is driven by a desire for control, access to information, and a growing skepticism of institutions.
There's an explosion in the use of peptides and GLP-1 drugs for a wide range of applications, from weight loss and injury repair to cognitive enhancement and anti-aging. Much of this activity occurs in unregulated 'gray' and 'black' markets.
The conversation details the widespread use of various substances, from FDA-approved drugs like Sunosi to gray-market peptides, to enhance focus, alertness, and physical capabilities. Huberman notes the high demand but also the inherent risks, such as sleep disruption and cardiovascular strain.
Huberman outlines the next frontier in health tech: moving from simply monitoring biological signals (e.g., sleep trackers) to actively influencing or 'writing' to biological systems. Examples include targeted cooling to induce sleep or mRNA vaccines reprogramming the immune system.
Keep pulling the thread on Andrew Huberman.